Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products!
Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GIR-M52H3 | Mouse | Mouse GITR / TNFRSF18 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GIR-H82E1 | Human | Biotinylated Human GITR / TNFRSF18 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
GIR-C52H6 | Canine | Canine GITR / TNFRSF18 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GIR-H82F7 | Human | Biotinylated Human GITR / TNFRSF18 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
GIR-H525a | Human | Human GITR / TNFRSF18 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
GIR-H5254 | Human | Human GITR / TNFRSF18 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
GIR-C5255 | Rhesus macaque | Rhesus macaque GITR / TNFRSF18 Protein, Fc Tag | ![]() |
![]() ![]() |
|
GIR-R5222 | Rat | Rat GITR / TNFRSF18 Protein, His Tag | ![]() |
![]() ![]() |
|
GIR-H5228 | Human | Human GITR / TNFRSF18 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized Human GITR Ligand, Fc Tag at 10 μg/mL (100 μL/well) can bind Biotinylated Human GITR, His,Avi tag™ (Cat. No. GIR-H82E1) with a linear range of 0.039-0.625 μg/mL (QC tested).
The purity of Biotinylated Human GITR Protein, His,Avitag (Cat. No. GIR-H82E1) is more than 95% and the molecular weight of this protein is around 20-30 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
BMS-986156 | BMS-986156 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Liver Neoplasms; Thoracic Neoplasms; Neoplasms; Lung Neoplasms | Details |
Ragifilimab | INCAGN-1876; INCAGN-01876; AGEN-1876; CM-701 | Phase 2 Clinical | Agenus Inc, Ludwig Institute For Cancer Research | Neoplasms; Neoplasm Metastasis | Details |
Anti-GITR antibody (BMS) | Phase 1 Clinical | Bristol-Myers Squibb Company | Neoplasms | Details | |
LY-3844583 | LY-3844583; LY3844583 | Phase 1 Clinical | Eli Lilly And Company | Dermatitis, Atopic | Details |
REGN-6569 | REGN-6569; REGN6569 | Phase 1 Clinical | Regeneron Pharmaceuticals Inc | Squamous Cell Carcinoma of Head and Neck | Details |
GWN-323 | GWN-323 | Phase 1 Clinical | Novartis Pharma Ag | Solid tumours; Lymphoma | Details |
MK-4166 | MK-4166 | Phase 1 Clinical | Merck & Co Inc | Solid tumours | Details |
This web search service is supported by Google Inc.